Page:Helsinn Healthcare S. A. v. Teva Pharmaceuticals USA, Inc., et al..pdf/11

Rh hold that an inventor’s sale of an invention to a third party who is obligated to keep the invention confidential can qualify as prior art under §102(a). We therefore affirm the judgment of the Federal Circuit. It is so ordered.